Section 4: Clinical Pharmacy Services 2023
DOI: 10.1136/ejhpharm-2023-eahp.206
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-225 Health impact of treatment for inflammatory bowel disease with biological agents from the patient’s perspective: a cross-sectional study using patient reported outcome measures (PROMs)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles